Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): A double-blind, randomised phase 3 trial
- Hansjochen Wilke*
- , Kei Muro
- , Eric Van Cutsem
- , Sang Cheul Oh
- , György Bodoky
- , Yasuhiro Shimada
- , Shuichi Hironaka
- , Naotoshi Sugimoto
- , Oleg Lipatov
- , Tae You Kim
- , David Cunningham
- , Philippe Rougier
- , Yoshito Komatsu
- , Jaffer Ajani
- , Michael Emig
- , Roberto Carlesi
- , David Ferry
- , Kumari Chandrawansa
- , Jonathan D. Schwartz
- , Atsushi Ohtsu
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
2243
Link opens in a new tab
Citations
(Scopus)